SCHEMBL4076909

SCHEMBL4076909

CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccc(F)cc2F)no1.CC(C)(C)c1cc(NC(=O)C(C)(C)S(=O)(=O)c2ccc3nsnc3c2)no1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.56
CNR1 P21554 5/20 0.56
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
MAPK14 Q16539 2/20 0.43
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
EGFR P00533 1/20 0.35
ATM Q13315 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464717 0.90 CNR2 (0.67) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1464450 0.87 CNR2 (0.62) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL4077579 0.85 CNR2 (0.64) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL766938 0.81 CNR2 (0.79) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1465839 0.79 CNR2 (0.65) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1465063 0.78 CNR2 (0.67) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1464880 0.78 CNR2 (0.61) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1464681 0.77 CNR2 (0.79) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1464517 0.77 CNR2 (0.69) CNR2CNR1RAB9ANPC1MAPK14
SCHEMBL1463932 0.77 CNR2 (0.72) CNR2CNR1RAB9ANPC1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP claimed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO claimed
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed